by admin | Apr 19, 2024 | Article
Despite the challenges of treating lupus, Dr. Zahi Touma is hopeful for the futures of people living with the complex autoimmune condition.https://www.healthing.ca/diseases-and-conditions/lupus/autoimmune-uhn
by admin | Apr 19, 2024 | Article
March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...
by admin | Apr 19, 2024 | Article
March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024. For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf
by admin | Apr 19, 2024 | Article
February 1, 2024 – Benlysta, a prescription drug used to treat adults with lupus as well as adults with lupus-related kidney inflammation (active lupus nephritis), has been included in the latest update of RAMQ’s list of medications published on February 1, 2024....
by admin | Apr 18, 2024 | Article
Let’s Talk Lupus – Educational Videos, a video series aimed to provide the lupus patient and/or caregivers with accurate up to date medical information on topics of interest. We surveyed lupus patients throughout the country and asked them, “If you could ask...
